Maintenance TMS in Treatment Resistant Depression
Key facts
- Who runs it
- Austin Messner
- Where
- Lexington, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 1 person enrolled
- Started
- 17 Apr 2025
- Ended
- 26 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transmagnetic Stimulation
- Electroconvulsive Therapy
- Record updated
- 12 May 2026
- Why it stopped
- Lack of enrollment
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients treated for TRD who have achieved remission through an index series of ECT
- Able to provide informed consent
- Age between 18 and 65 years
- Deemed appropriate for maintenance TMS by their psychiatrist
- Right-handed
Who cannot take part
- History of seizures or a seizure disorder
- Related neurological disorder, or any other medical condition that would preclude TMS treatment determined by the treatment team
Where in United States
- University of KentuckyLexington, United States
About the trial
What the trial wants to find out
Electroconvulsive therapy (ECT) is one of the most efficacious treatments available for treatment-resistant depression (TRD). Although a maintenance ECT protocol exists, multiple barriers limit its use for long-term use. These barriers include procedure tolerability, cognitive side effects, financial burden, and unreliable social support to accompany patients for these treatments. On the other hand, a different modality of noninvasive neuromodulation called transcranial magnetic stimulation (TMS) can be performed in the outpatient setting and does not need anesthesia. The likelihood of cognitive adverse effects with TMS is much lower than with ECT. Our clinical question encompasses piloting a maintenance TMS regimen to maintain remission in treatment-resistant major depressive disorder.
Read full original descriptionShow less
This will be a patient-preference clinical trial, with patients offered the choice to initiate maintenance TMS versus maintenance ECT after their index ECT sessions for treatment-resistant depression. There will be no randomization or placebo involved in this study.
The 2 groups in the trial
- TMSTreatment being tested
Patients who have achieved remission of treatment resistant depression through an initial course of ECT (8 to 12 sessions) at the University of Kentucky will be identified by the ECT attending physician as a candidate for this study. They will receive TMS in this arm of study for maintenance treatment of their depression and monitored with depressive scales.
Treatment: Transmagnetic Stimulation
- ECTExisting treatment, for comparison
Patients who have achieved remission of treatment resistant depression through an initial course of ECT (8 to 12 sessions) at the University of Kentucky will be identified by the ECT attending physician as a candidate for this study. If they elect to continue with maintenance ECT treatments which is the current standard of care, their depressive symptoms and cognitive functioning will be monitored accordingly.
Treatment: Electroconvulsive Therapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transitioning From Maintenance ECT to Maintenance TMS in Treatment Resistant Depression
- Record updated
- 12 May 2026